 |
Johnathan M. Lancaster, M.D. , Ph.D. Assistant Professor in the Interdisciplinary Oncology Program Division Chief, Gynecologic Oncology Program Medical Director, Lifetime Cancer Screening & Prevention Center Member-in-Residence of the Moffitt Cancer Center E-mail:
Johnathan.Lancaster@moffitt.org |
Training
B. Sc.: University of Wales College of Medicine, 1991.
MB, B.Ch.: University of Wales College of Medicine, 1992.
M.D.: University of Wales College of Medicine, Molecular Genetics, 1997.
Ph.D.: University of Wales College of Medicine, Molecular Genetics, 2005
Fogarty Research Fellow: NIEHS, NIH, North Carolina, 1996.
Research Associate: Duke University Medical Center, Dept. of Surgery, 1997.
Resident: Duke University Medical Center, Obstetrics & Gynecology, 2000.
Fellow: Duke University Medical Center, Gynecologic Oncology, 2003.
Research Interests
Dr. Lancaster's active research program is investigating the molecular genetic etiology of ovarian cancer development, progression, and response to therapy. Translational applications of this research are anticipated to include microarray expression profile-directed chemotherapeutic interventions for primary and recurrent ovarian cancer.
Search
for publications by: 
This
search will be conducted at the US National Library of Medicine (NLM) and PubMed.
Selected Publications
A Bild, G Yao, J Chang, Q Wang, A Potti, D Chasse, M Joshi, D Harpole, JM Lancaster, A Berchuck, J Olson Jr, J Marks, H Dressman, M West, J Nevins. Signatures of Oncogenic Pathway Deregulation in Human Cancers. Nature, 19;439(7074):353-7, 2006
JM Lancaster, R Sayer, J Pittman, J Gray, R Whitaker, I Konidari, D Schomberg, J Marks, A Berchuck. High expression of insulin-like growth factor binding protein-2 (IGFBP-2) in epithelial ovarian cancers produces elevated pre-operative serum levels. International Journal of Gynecological Cancer, 16:1529-1535, 2006
JM Lancaster, H Dressman, J Pittman, R Sayer, M Martino, J Cragun. A Henriott, J Gray, R Sutphen, A Elahi, R Whitaker, M West, J Marks, R Nevins, A Berchuck. Identification of genes associated with ovarian cancer metastasis using microarray expression analysis.International Journal of Gynecological Cancer, 16:1733-1745, 2006
Anil Potti, Holly K. Dressman, Andrea Bild, Richard F. Riedel, Gina Chan, Robyn Sayer, Janiel Cragun, Hope Cottrill, Michael J. Kelley, Rebecca Petersen, David Harpole, Jeffrey Marks, Andrew Berchuck, Geoffrey S. Ginsburg, Phillip Febbo, JM Lancaster, and Joseph R. Nevins. A Genomic Strategy to Guide Use of Chemotherapeutics in Solid Tumors. Nature Medicine, 12(11):1294-300, 2006
HK Dressman, A Berchuck, G Chan, J Zhai, A Bild, R Sayer, J Cragun, J Clarke, RS Whitaker, LiHua Li, Jonathan Gray, Jeffrey Marks, GS Ginsburg, A Potti, M West, JR Nevins, JM Lancaster. An Integrated Genomic-Based Approach to Personalized Treatment of Patients with Advanced-Stage Ovarian Cancer. Journal of Clinical Oncology Feb 10;25(5):517-25, 2007
Cancer Biology Ph.D. Program
H. Lee Moffitt Cancer Center, MRC-4 East
12902 Magnolia Drive
Tampa, Florida 33612
Phone: 813-745-6876
E-mail: CancerPHD@moffitt.org
Copyright © 2000 University of South Florida